Behçet's disease epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Removing from Primary care)
 
(25 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Behçet's disease}}
{{Behçet's disease}}
{{CMG}}; {{AE}} {{HQ}}
{{CMG}}; {{AE}} {{HQ}}{{MA}}


==Overview==
==Overview==
The [[prevalence]] of Behçet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States. Behçet disease commonly affects young adults 20 to 40 years of age. [[Male|Males]] are more commonly affected by Behçet disease than [[Female|females]]. Behçet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are more likely to develop Behçet disease due to the increased incidence of [[skin]] pathergy and [[Human leukocyte antigen|HLA]]-B51 [[antigen]]. The [[male]] to [[female]] ratio ranges from approximately 11 to 1 to 2 to 1. The majority of Behçet disease cases are reported along the ancient silk road (from eastern Asia to the Mediterranean).


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
===Prevalence===
* The prevalence of behcet disease is approximately 80 to 370 per 100,000 individuals in Turkey. <ref name="pmid10528040" />
* The [[prevalence]] of Behçet disease is approximately 80 to 370 per 100,000 individuals in Turkey.<ref name="pmid10528040" /><ref name="pmid16911374">{{cite journal| author=Sarica-Kucukoglu R, Akdag-Kose A, KayabalI M, Yazganoglu KD, Disci R, Erzengin D et al.| title=Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases. | journal=Int J Dermatol | year= 2006 | volume= 45 | issue= 8 | pages= 919-21 | pmid=16911374 | doi=10.1111/j.1365-4632.2006.02832.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16911374  }} </ref>
* The prevalence of behcet disease is approximately 13.5 to 20 per 100,000 individuals in Iran,  Japan, Korea, China and Saudi Arabia. <ref name="pmid10528040" />
* The [[prevalence]] of Behçet disease is approximately 13.5 to 20 per 100,000 individuals in Iran,  Japan, Korea, China and Saudi Arabia.<ref name="pmid10528040" />
* The prevalence of behcet disease is approximately 7.1  per 100,000 individuals in Paris, France.<ref name="pmid19035493">{{cite journal |vauthors=Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L |title=Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration |journal=Arthritis Rheum. |volume=58 |issue=12 |pages=3951–9 |date=December 2008 |pmid=19035493 |doi=10.1002/art.24149 |url=}}</ref>  
* The [[prevalence]] of Behçet disease is approximately 7.1  per 100,000 individuals in Paris, France.<ref name="pmid19035493">{{cite journal |vauthors=Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L |title=Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration |journal=Arthritis Rheum. |volume=58 |issue=12 |pages=3951–9 |date=December 2008 |pmid=19035493 |doi=10.1002/art.24149 |url=}}</ref>  
*  The prevalence of behcet disease is approximately 2.4 per 100,000 individuals in European ancestry<ref name="pmid19035493" />  
* The [[prevalence]] of Behçet disease is approximately 2.4 per 100,000 individuals in European ancestry.<ref name="pmid19035493" />  
*  The prevalence of behcet disease is approximately 34.6 per 100,000 individuals in North African ancestry<ref name="pmid19035493" />  
* The [[prevalence]] of Behçet disease is approximately 34.6 per 100,000 individuals in North African ancestry.<ref name="pmid19035493" />  
* The prevalence of behcet disease is approximately 17.5 per 100,000 individuals in Asian ancestry<ref name="pmid19035493" />  
* The [[prevalence]] of Behçet disease is approximately 17.5 per 100,000 individuals in Asian ancestry.<ref name="pmid19035493" />  
* The prevalence of behcet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States. <ref name="pmid19405011">{{cite journal |vauthors=Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM |title=Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study |journal=Arthritis Rheum. |volume=61 |issue=5 |pages=600–4 |date=May 2009 |pmid=19405011 |pmc=3024036 |doi=10.1002/art.24423 |url=}}</ref>  
* The [[prevalence]] of Behçet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States.<ref name="pmid19405011">{{cite journal |vauthors=Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM |title=Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study |journal=Arthritis Rheum. |volume=61 |issue=5 |pages=600–4 |date=May 2009 |pmid=19405011 |pmc=3024036 |doi=10.1002/art.24423 |url=}}</ref>
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Behçet disease commonly affects young adults 20 to 40 years of age.<ref name="pmid105280403">{{cite journal |vauthors=Sakane T, Takeno M, Suzuki N, Inaba G |title=Behçet's disease |journal=N. Engl. J. Med. |volume=341 |issue=17 |pages=1284–91 |date=October 1999 |pmid=10528040 |doi=10.1056/NEJM199910213411707 |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*Behcet disease commonly affects young adults 20 to 40 years of age.<ref name="pmid105280403">{{cite journal |vauthors=Sakane T, Takeno M, Suzuki N, Inaba G |title=Behçet's disease |journal=N. Engl. J. Med. |volume=341 |issue=17 |pages=1284–91 |date=October 1999 |pmid=10528040 |doi=10.1056/NEJM199910213411707 |url=}}</ref>


===Race===
===Race===
*Behcet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are more likely to develop Behcet disease due to theincreased incidence of skin pathergy and HLA-B51 antigen.
*Behçet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations.  
*Middle Eastern and Asian individuals are more likely to develop Behçet disease due to the increased [[incidence]] of [[skin]] pathergy and [[Human leukocyte antigen|HLA]]-B51 [[antigen]].


===Gender===
===Gender===
*Males are more commonly affected by Behcet disease than females. The male to female ratio ranges from approximately 11 to 1 to 2 to 1.
*[[Male|Males]] are more commonly affected by Behçet disease than [[Female|females]]. The [[male]] to [[female]] ratio ranges from approximately 11 to 1 to 2 to 1.


===Region===
===Region===
*The majority of behcet disease cases are reported along the ancient silk road ( from eastern Asia to the Mediterranean)<ref name="pmid10528040">{{cite journal |vauthors=Sakane T, Takeno M, Suzuki N, Inaba G |title=Behçet's disease |journal=N. Engl. J. Med. |volume=341 |issue=17 |pages=1284–91 |date=October 1999 |pmid=10528040 |doi=10.1056/NEJM199910213411707 |url=}}</ref>
*The majority of Behçet disease cases are reported along the ancient silk road (from eastern Asia to the Mediterranean).<ref name="pmid10528040">{{cite journal |vauthors=Sakane T, Takeno M, Suzuki N, Inaba G |title=Behçet's disease |journal=N. Engl. J. Med. |volume=341 |issue=17 |pages=1284–91 |date=October 1999 |pmid=10528040 |doi=10.1056/NEJM199910213411707 |url=}}</ref>
*Behcet disease is most common in Trukey.  
*Behçet disease is most common in Turkey.
*
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===


===Developing Countries===
===Neurologic disease===  
*Occurs in less than 10 percent of patients with Behçet syndrome in most series.<ref name="pmid9591220">{{cite journal| author=Serdaroğlu P| title=Behçet's disease and the nervous system. | journal=J Neurol | year= 1998 | volume= 245 | issue= 4 | pages= 197-205 | pmid=9591220 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9591220  }} </ref><ref name="pmid19444529">{{cite journal| author=Siva A, Saip S| title=The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. | journal=J Neurol | year= 2009 | volume= 256 | issue= 4 | pages= 513-29 | pmid=19444529 | doi=10.1007/s00415-009-0145-6 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19444529  }} </ref><ref name="pmid19161910">{{cite journal| author=Al-Araji A, Kidd DP| title=Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. | journal=Lancet Neurol | year= 2009 | volume= 8 | issue= 2 | pages= 192-204 | pmid=19161910 | doi=10.1016/S1474-4422(09)70015-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19161910  }} </ref>
*[[Male|Males]] are more commonly affected by neurological Behçet disease than [[Female|females]].


==References==
==References==
Line 45: Line 38:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Autoimmune diseases]]
 
[[Category:Medicine]]
[[Category:Up-To-date]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]

Latest revision as of 20:36, 29 July 2020

Behçet's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Behçet's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Behçet's disease epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Behçet's disease epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Behçet's disease epidemiology and demographics

CDC on Behçet's disease epidemiology and demographics

Behçet's disease epidemiology and demographics in the news

Blogs on Behçet's disease epidemiology and demographics</smal

Directions to Hospitals Treating Behçet's disease

Risk calculators and risk factors for Behçet's disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]Mahda Alihashemi M.D. [3]

Overview

The prevalence of Behçet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States. Behçet disease commonly affects young adults 20 to 40 years of age. Males are more commonly affected by Behçet disease than females. Behçet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are more likely to develop Behçet disease due to the increased incidence of skin pathergy and HLA-B51 antigen. The male to female ratio ranges from approximately 11 to 1 to 2 to 1. The majority of Behçet disease cases are reported along the ancient silk road (from eastern Asia to the Mediterranean).

Epidemiology and Demographics

Prevalence

  • The prevalence of Behçet disease is approximately 80 to 370 per 100,000 individuals in Turkey.[1][2]
  • The prevalence of Behçet disease is approximately 13.5 to 20 per 100,000 individuals in Iran, Japan, Korea, China and Saudi Arabia.[1]
  • The prevalence of Behçet disease is approximately 7.1 per 100,000 individuals in Paris, France.[3]
  • The prevalence of Behçet disease is approximately 2.4 per 100,000 individuals in European ancestry.[3]
  • The prevalence of Behçet disease is approximately 34.6 per 100,000 individuals in North African ancestry.[3]
  • The prevalence of Behçet disease is approximately 17.5 per 100,000 individuals in Asian ancestry.[3]
  • The prevalence of Behçet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States.[4]

Age

  • Behçet disease commonly affects young adults 20 to 40 years of age.[5]

Race

  • Behçet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations.
  • Middle Eastern and Asian individuals are more likely to develop Behçet disease due to the increased incidence of skin pathergy and HLA-B51 antigen.

Gender

  • Males are more commonly affected by Behçet disease than females. The male to female ratio ranges from approximately 11 to 1 to 2 to 1.

Region

  • The majority of Behçet disease cases are reported along the ancient silk road (from eastern Asia to the Mediterranean).[1]
  • Behçet disease is most common in Turkey.

Neurologic disease

  • Occurs in less than 10 percent of patients with Behçet syndrome in most series.[6][7][8]
  • Males are more commonly affected by neurological Behçet disease than females.

References

  1. ↑ 1.0 1.1 1.2 Sakane T, Takeno M, Suzuki N, Inaba G (October 1999). "Behçet's disease". N. Engl. J. Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.
  2. ↑ Sarica-Kucukoglu R, Akdag-Kose A, KayabalI M, Yazganoglu KD, Disci R, Erzengin D; et al. (2006). "Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases". Int J Dermatol. 45 (8): 919–21. doi:10.1111/j.1365-4632.2006.02832.x. PMID 16911374.
  3. ↑ 3.0 3.1 3.2 3.3 Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (December 2008). "Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration". Arthritis Rheum. 58 (12): 3951–9. doi:10.1002/art.24149. PMID 19035493.
  4. ↑ Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (May 2009). "Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study". Arthritis Rheum. 61 (5): 600–4. doi:10.1002/art.24423. PMC 3024036. PMID 19405011.
  5. ↑ Sakane T, Takeno M, Suzuki N, Inaba G (October 1999). "Behçet's disease". N. Engl. J. Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.
  6. ↑ Serdaroğlu P (1998). "Behçet's disease and the nervous system". J Neurol. 245 (4): 197–205. PMID 9591220.
  7. ↑ Siva A, Saip S (2009). "The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis". J Neurol. 256 (4): 513–29. doi:10.1007/s00415-009-0145-6. PMID 19444529.
  8. ↑ Al-Araji A, Kidd DP (2009). "Neuro-Behçet's disease: epidemiology, clinical characteristics, and management". Lancet Neurol. 8 (2): 192–204. doi:10.1016/S1474-4422(09)70015-8. PMID 19161910.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Behçet%27s_disease_epidemiology_and_demographics&oldid=1635129"